POSTMENOPAUSAL OSTEOPOROTIC WOMEN TREATED WITH PTH 1-84: EVALUATION OF OUTCOMES

被引：0
|
作者：
Pastore, Renato [1 ]
Chioma, Laura [2 ]
Borboni, Patrizia [2 ]
Vancieri, Giuseppe [2 ]
Mentuccia, Daniela [1 ]
Frajese, Giovanni Vanni [3 ]
机构：
[1] Osped Fatebenefratelli S Giovanni Calibita Isola, UOC Endocrinol, Rome, Italy
[2] Univ Roma Tor Vergata, Rome, Italy
[3] Univ Cassino, Fac Sci Motorie & Salute, Frosinone, Italy
来源：
OSTEOPOROSIS INTERNATIONAL | 2011年 / 22卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：395 / 395
页数：1
相关论文
共 50 条
  • [41] Full length parathyroid hormone (1-84) in the treatment of osteoporosis in postmenopausal women
    Jodar-Gimeno, Esteban
    CLINICAL INTERVENTIONS IN AGING, 2007, 2 (01) : 163 - 174
  • [42] Effect of PTH (1-84) on the increase in BMD and pain reduction in a retrospective study of patients with osteoporotic vertebral fractures
    Garcia-Ameijeiras, M. C.
    Gomez-Garrido, A.
    Tovar-Felice, M.
    Cano, S.
    17TH ESPRM EUROPEAN CONGRESS OF PHYSICAL AND REHABILITATION MEDICINE, 2010, : 284 - +
  • [43] Improved adherence with PTH(1-84) in an extension trial for 24 months results in enhanced BMD gains in the treatment of postmenopausal women with osteoporosis
    Black, D. M.
    Bilezikian, J. P.
    Greenspan, S. L.
    Wuester, C.
    Munoz-Torres, M.
    Bone, H. G.
    Rosen, C. J.
    Andersen, H. S.
    Hanley, D. A.
    OSTEOPOROSIS INTERNATIONAL, 2013, 24 (04) : 1503 - 1511
  • [44] An amino-terminal form of PTH different from hPTH(1-84) is detected by a cyclase-activating PTH assay specific for hPTH(1-84). Clinical evaluation.
    D'Amour, P
    Rousseau, L
    Brossard, JH
    Cantor, T
    Gao, P
    JOURNAL OF BONE AND MINERAL RESEARCH, 2002, 17 : S391 - S391
  • [45] Clinical evaluation of two novel biointact PTH(1-84) assays in hemodialysis patients
    Hecking, Manfred
    Kainz, Alexander
    Bielesz, Bernhard
    Plischke, Max
    Beilhack, Georg
    Hoerl, Walter H.
    Sunder-Plassmann, Gere
    Bieglmayer, Christian
    CLINICAL BIOCHEMISTRY, 2012, 45 (18) : 1645 - 1651
  • [46] Postmenopausal women treated with combination parathyroid hormone (1-84) and ibandronate demonstrate different microstructural changes at the radius vs. tibia: the PTH and Ibandronate Combination Study (PICS)
    Schafer, A. L.
    Burghardt, A. J.
    Sellmeyer, D. E.
    Palermo, L.
    Shoback, D. M.
    Majumdar, S.
    Black, D. M.
    OSTEOPOROSIS INTERNATIONAL, 2013, 24 (10) : 2591 - 2601
  • [47] The effect of hepatic or renal impairment on the pharmacokinetics of PTH (1-84).
    Wells, D. S.
    JOURNAL OF BONE AND MINERAL RESEARCH, 2006, 21 : S301 - S301
  • [48] Changes in bone turnover markers and BMD in women with osteoporosis after PTH 1-84 treatment
    Pastore, R.
    Mentuccia, D.
    Borboni, P.
    Frajese, V.
    BONE, 2009, 44 (02) : S440 - S441
  • [49] PARATHYROID HORMONE 1-84 EQUIVALENT VALUE TO INTACT PTH
    Kim, Beom
    Lee, Dong-Young
    Yang, Soohyun
    Kim, Hye Won
    Moon, Kyoung Hyoub
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2014, 29 : 390 - 390
  • [50] Primary hyperparathyroidism with normal intact (1-84) PTH.
    Tamborenea, MI
    Karlsbrunn, S
    Fogiel, F
    Torrecilla, I
    Lijeron, L
    Brussa, M
    Salerni, H
    JOURNAL OF BONE AND MINERAL RESEARCH, 1996, 11 : T745 - T745
12345